CSRxP: STRONGER Patents Act Could Further Enable Big Pharma’s Patent Abuse
Proposed Bill Would Undermine Fair and Efficient Review Process Washington,… Read More
Proposed Bill Would Undermine Fair and Efficient Review Process Washington,… Read More
Senators Advance Three Measures to Help Lower Drug Prices as Momentum to Hold… Read More
Advancement of CREATES and FAIR Drug Pricing Acts Marks Step Toward Boosting… Read More
This week, Big Pharma giant AbbVie announced plans to acquire drug maker… Read More
Encourages Senate Panel to Further Strengthen Drug Price Package with REMEDY… Read More
Report Finds Significant Catastrophic Liability for Drug Makers Benefits… Read More
Current Trade Agreement Could Hamper Generic and Biosimilar Competition… Read More
Greater List Price Transparency Will Help Crack Down on Big Pharma’s… Read More
Drug Makers Intensify Blame Game While Seeking to Avoid Accountability… Read More
Poll Finds U.S. Adults Blame Drug Makers for Rising Prices, Oppose… Read More
Bipartisan CREATES, FAIR Drug Pricing and REMEDY Acts Will Deliver Relief for… Read More
Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today… Read More